What contraceptive is suitable for a 20-year-old with abnormal uterine bleeding (AUB)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Combined Oral Contraceptives for Abnormal Uterine Bleeding in a 20-Year-Old

Combined oral contraceptives (COCs) are the most appropriate contraceptive choice for a 20-year-old with abnormal uterine bleeding (AUB) due to their ability to regulate bleeding patterns and provide effective contraception. 1

Benefits of COCs for Abnormal Uterine Bleeding

  • COCs provide significant noncontraceptive benefits including decreased menstrual cramping, reduced blood loss, and improvement in acne 1
  • Extended or continuous COC regimens are particularly appropriate for patients with abnormal uterine bleeding, anemia, and bleeding disorders 1
  • COCs can establish regular bleeding patterns or amenorrhea, which is a primary goal in AUB management 2
  • COCs are one of the best-studied medications ever prescribed and are completely reversible with no negative effect on long-term fertility 1

Recommended COC Regimen

  • Start with a monophasic pill containing 30-35 μg of ethinyl estradiol and a progestin such as levonorgestrel or norgestimate 1
  • Consider extended or continuous cycle regimens to optimize ovarian suppression and minimize fluctuations, which may be particularly beneficial for AUB 1
  • Standard pill packs include 28 pills total, with 21-24 hormone pills and 4-7 placebo pills 1
  • For severe AUB, extended cycle regimens with shorter or no hormone-free intervals may provide better bleeding control 1

Alternative Options If COCs Are Not Suitable

  • Levonorgestrel intrauterine device (LNG-IUD) - highly effective for controlling bleeding with localized hormonal effect 1
  • Progestin-only pills - option for patients with contraindications to estrogen 1
  • Injectable contraceptives (DMPA) - can reduce or eliminate bleeding over time 1
  • Contraceptive implant with supplemental treatment for bleeding irregularities 1

Management of Breakthrough Bleeding

If breakthrough bleeding occurs while using COCs:

  • Rule out underlying gynecological problems, STIs, pregnancy, or pathologic uterine conditions 1
  • For persistent irregular bleeding with COCs, consider:
    • Increasing estrogen content from 20 mcg to 35 mcg per day 3
    • Decreasing the hormone-free interval (from seven to four or five days) 1, 3
    • Short-term NSAID treatment (5-7 days) during days of bleeding 1

Important Considerations and Contraindications

  • COCs should not be prescribed for patients with:
    • Severe uncontrolled hypertension (≥160/100 mmHg)
    • Ongoing hepatic dysfunction
    • Complicated valvular heart disease
    • Migraines with aura or focal neurologic symptoms
    • Thromboembolism or thrombophilia 1
  • The baseline risk of venous thromboembolism in adolescents is up to 1 per 10,000 woman-years, and COCs increase this risk three to fourfold 1
  • Missed pills reduce effectiveness - counsel on adherence strategies and what to do if pills are missed 1

Algorithm for Selecting Contraception in AUB

  1. First-line: Combined oral contraceptives (30-35 μg ethinyl estradiol) if no contraindications 1
  2. If estrogen is contraindicated: Consider LNG-IUD or progestin-only methods 1
  3. If heavy bleeding requires immediate control: Consider extended or continuous COC regimen 1
  4. If bleeding persists despite COC use:
    • Verify correct use and adherence 1
    • Consider short-term NSAID treatment 1
    • Evaluate for underlying pathology 1, 2

COCs provide both effective contraception and treatment for the underlying abnormal bleeding, making them the optimal choice for a 20-year-old with AUB 1, 4.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Abnormal uterine bleeding: The well-known and the hidden face.

Journal of endometriosis and uterine disorders, 2024

Research

Abnormal uterine bleeding and dysfunctional uterine bleeding in pediatric and adolescent gynecology.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.